Trial intelligence / Profile preview

Sertraline anti-inflammatory effect in hemodialysis patients with depression

IRCT201111228171N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of sertraline in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Apr 2012; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on IRCT201111228171N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201111228171N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call